Matinas BioPharma Stock Forecast - Accumulation Distribution
| MTNB Stock | USD 1.17 0.11 8.59% |
Matinas Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Matinas BioPharma stock prices and determine the direction of Matinas BioPharma Holdings's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Matinas BioPharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At present, Matinas BioPharma's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.04, whereas Fixed Asset Turnover is forecasted to decline to 0.15. . As of November 12, 2025, Common Stock Shares Outstanding is expected to decline to about 4.6 M. In addition to that, Net Loss is expected to decline to about (19.8 M). | Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 1711.88 | 0.12 |
| Check Matinas BioPharma Volatility | Backtest Matinas BioPharma | Information Ratio |
Matinas BioPharma Trading Date Momentum
| On November 12 2025 Matinas BioPharma Holdings was traded for 1.17 at the closing time. The top price for the day was 1.33 and the lowest listed price was 1.17 . There was no trading activity during the period 0.0. Lack of trading volume on November 12, 2025 did not cause price change. The trading delta at closing time against the current closing price is 9.40% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Matinas BioPharma to competition |
Other Forecasting Options for Matinas BioPharma
For every potential investor in Matinas, whether a beginner or expert, Matinas BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Matinas Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Matinas. Basic forecasting techniques help filter out the noise by identifying Matinas BioPharma's price trends.Matinas BioPharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Matinas BioPharma stock to make a market-neutral strategy. Peer analysis of Matinas BioPharma could also be used in its relative valuation, which is a method of valuing Matinas BioPharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Matinas BioPharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Matinas BioPharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Matinas BioPharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Matinas BioPharma Market Strength Events
Market strength indicators help investors to evaluate how Matinas BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Matinas BioPharma shares will generate the highest return on investment. By undertsting and applying Matinas BioPharma stock market strength indicators, traders can identify Matinas BioPharma Holdings entry and exit signals to maximize returns.
Matinas BioPharma Risk Indicators
The analysis of Matinas BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Matinas BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting matinas stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.75 | |||
| Semi Deviation | 6.79 | |||
| Standard Deviation | 10.03 | |||
| Variance | 100.51 | |||
| Downside Variance | 52.29 | |||
| Semi Variance | 46.12 | |||
| Expected Short fall | (7.27) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Matinas BioPharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Matinas BioPharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Matinas Biopharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Matinas Biopharma Holdings Stock:Check out Historical Fundamental Analysis of Matinas BioPharma to cross-verify your projections. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Matinas BioPharma. If investors know Matinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Matinas BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Matinas BioPharma is measured differently than its book value, which is the value of Matinas that is recorded on the company's balance sheet. Investors also form their own opinion of Matinas BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Matinas BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Matinas BioPharma's market value can be influenced by many factors that don't directly affect Matinas BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Matinas BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Matinas BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Matinas BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.